The real decoy: an antidote for factor Xa-directed anticoagulants.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Andexanet alfa-induced heparin resistance during percutaneous coronary intervention for ST-elevation myocardial infarction: a case report.European heart journal. Case reports · 2025
   Article
2. Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study.The western journal of emergency medicine · 2023
   Observational
3. The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review.Thrombosis journal · 2023
   Review
4. Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.Medicines (Basel, Switzerland) · 2019
   Review
5. Andexanet Alfa (AndexxaP & T : a peer-reviewed journal for formulary management · 2019
   Article
6. Emergency Reversal of Anticoagulation.The western journal of emergency medicine · 2019
   Review
7. Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.Journal of thrombosis and thrombolysis · 2018
   Review
8. Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.Current cardiology reports · 2017
   Review
9. Reversing factor Xa inhibitors - clinical utility of andexanet alfa.Journal of blood medicine · 2017
   Review
10. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article

Corrections and comments

• Comment on
  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.2013

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as